Gene · 5670
Papers3,544
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,544
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Establishment and characterization of a new intestinal-type ampullary carcinoma cell line, DPC-X3. | BMC Cancer | 2024 | 39707230 | PubTator, text mining | PubMed |
| Emerging Trends in Integrated Digital Microfluidic Platforms for Next-Generation Immunoassays. | Micromachines (Basel) | 2024 | 39597170 | PubTator, text mining | PubMed |
| Gut commensal Alistipes as a potential pathogenic factor in colorectal cancer. | Discov Oncol | 2024 | 39331213 | PubTator, text mining | PubMed |
| Application and Method of Surface Plasmon Resonance Technology in the Preparation and Characterization of Biomedical Nanoparticle Materials. | Int J Nanomedicine | 2024 | 39011388 | PubTator, text mining | PubMed |
| Efficacy and safety analysis of PD-1 combined with regorafenib in the treatment of advanced hepatocellular carcinoma. | Am J Transl Res | 2024 | 39006269 | PubTator, text mining | PubMed |
| SERPINC1, a new prognostic predictor of colon cancer, promote colon cancer progression through EMT. | Cancer Rep (Hoboken) | 2024 | 38923313 | PubTator, text mining | PubMed |
| Classification and applications of nanomaterials in vitro diagnosis. | Heliyon | 2024 | 38868029 | PubTator, text mining | PubMed |
| An On-Treatment Decreased Trend of Serum IL-6 and IL-8 as Predictive Markers Quickly Reflects Short-Term Efficacy of PD-1 Blockade Immunochemotherapy in Patients with Advanced Gastric Cancer. | J Immunol Res | 2024 | 38774604 | PubTator, text mining | PubMed |
| Aberrant methylation of placental development genes in chorionic villi of spontaneous abortions with trisomy 16. | Vavilovskii Zhurnal Genet Selektsii | 2024 | 38680176 | PubTator, text mining | PubMed |
| Evaluation of the Comparability of Wantai Wan200+ Instrument with Routine Laboratory Assays for 21 Different Analytes. | J Clin Med | 2024 | 38673517 | PubTator, text mining | PubMed |
| Clinical value of KiSS-1 and MMP-2 expression levels in breast cancer tissue in evaluating prognosis of elderly breast cancer patients after modified radical mastectomy. | Cell Mol Biol (Noisy-le-grand) | 2024 | 38650158 | PubTator, text mining | PubMed |
| Clinical Value of Human Endogenous Retrovirus-H Long Terminal Repeat Associating 2 (HHLA2) in Small Cell Lung Cancer. | Technol Cancer Res Treat | 2024 | 38613340 | PubTator, text mining | PubMed |
| Development and validation of a model and nomogram for breast cancer diagnosis based on quantitative analysis of serum disease-specific haptoglobin N-glycosylation. | J Transl Med | 2024 | 38575942 | PubTator, text mining | PubMed |
| Neutrophil Gelatinase-Associated Lipocalin for the Differentiation of Mucinous Pancreatic Cystic Lesions. | Int J Mol Sci | 2024 | 38542201 | PubTator, text mining | PubMed |
| [Overexpression of BZW1 promotes invasion and metastasis of gastric cancer cells by regulating Wnt/β-catenin signaling and promoting epithelial-mesenchymal transition]. | Nan Fang Yi Ke Da Xue Xue Bao | 2024 | 38501421 | PubTator, text mining | PubMed |
| Evaluating the comprehensive diagnosis efficiency of lung cancer, including measurement of SHOX2 and RASSF1A gene methylation. | BMC Cancer | 2024 | 38429660 | PubTator, text mining | PubMed |
| Hybrid Impedimetric Biosensors for Express Protein Markers Detection. | Micromachines (Basel) | 2024 | 38398911 | PubTator, text mining | PubMed |
| Genetic Impact of HOTAIR, LINC00951, POLR2E and HULC Polymorphisms in Histopathological and Laboratory Prognostic Factors in Esophageal Cancer in the West: A Case-Control Study. | Cancers (Basel) | 2024 | 38339289 | PubTator, text mining | PubMed |
| sPD-L1 and sPD-L2 in plasma of patients with lung cancer and their clinical significance. | Cytokine | 2024 | 38330638 | PubTator, text mining | PubMed |
| Serum antibody screening using glycan arrays. | Chem Soc Rev | 2024 | 38305761 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5670/papers?page=6